United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 21, 2026 · Filed Jul 22, 2026

On Jul 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$532.24 for US$5.06M under a trading plan, leaving 324,443 shares. Filed Jul 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$532.24 average (US$524.37 to US$536.37)
Value
US$5.06M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 21, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 21, 2026Common StockSale120US$524.37333,823Indirect
Jul 21, 2026Common StockSale160US$526.24333,663Indirect
Jul 21, 2026Common StockSale240US$527.46333,423Indirect
Jul 21, 2026Common StockSale509US$529.55332,914Indirect
Jul 21, 2026Common StockSale1,926US$530.50330,988Indirect
Jul 21, 2026Common StockSale2,605US$531.52328,383Indirect
Jul 21, 2026Common StockSale360US$532.47328,023Indirect
Jul 21, 2026Common StockSale640US$533.58327,383Indirect
Jul 21, 2026Common StockSale1,760US$534.61325,623Indirect
Jul 21, 2026Common StockSale341US$535.44325,282Indirect
Jul 21, 2026Common StockSale839US$536.37324,443Indirect

Source

View original at SEC

Related